Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Active Pharmaceutical Ingredients Market, Type of Synthesis
7.1. Active Pharmaceutical Ingredients Market, Type of Synthesis Type, 2020-2030
7.1.1. Biotech
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Synthetic
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer
8.1. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2020-2030
8.1.1. Captive APIs
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Merchant APIs
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Active Pharmaceutical Ingredients Market, By Type
9.1. Active Pharmaceutical Ingredients Market, By Type, 2020-2030
9.1.1. Generic APIs
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Innovative APIs
9.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Active Pharmaceutical Ingredients Market, By Application
10.1. Active Pharmaceutical Ingredients Market, By Application, 2020-2030
10.1.1. Cardiovascular Diseases
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Oncology
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. CNS and Neurology
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Orthopedic
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Endocrinology
10.1.5.1. Market Revenue and Forecast (2016-2030)
10.1.6. Pulmonology
10.1.6.1. Market Revenue and Forecast (2016-2030)
10.1.7. Gastroenterology
10.1.7.1. Market Revenue and Forecast (2016-2030)
10.1.8. Nephrology
10.1.8.1. Market Revenue and Forecast (2016-2030)
10.1.9. Ophthalmology
10.1.9.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Active Pharmaceutical Ingredients Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.1.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.1.3. Market Revenue and Forecast, By Type (2016-2030)
11.1.4. Market Revenue and Forecast, By Application (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, By Application (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.2.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.2.3. Market Revenue and Forecast, By Type (2016-2030)
11.2.4. Market Revenue and Forecast, By Application (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, By Application (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, By Application (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, By Application (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.3.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.3.3. Market Revenue and Forecast, By Type (2016-2030)
11.3.4. Market Revenue and Forecast, By Application (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, By Application (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, By Application (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, By Application (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.4.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.4.3. Market Revenue and Forecast, By Type (2016-2030)
11.4.4. Market Revenue and Forecast, By Application (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, By Application (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, By Application (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, By Application (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.5.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.5.3. Market Revenue and Forecast, By Type (2016-2030)
11.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, Type of Synthesis (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Type of Manufacturer (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, By Application (2016-2030)
Chapter 12. Company Profiles
12.1. Merck & Co., Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. AbbVie, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bristol-Myers Squibb Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Boehringer Ingelheim International GmbH
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cipla, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Teva Pharmaceutical Industries Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Albemarle Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Viatris Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Aurobindo Pharma
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Sun Pharmaceutical Industries Ltd.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Dr. Reddy’s Laboratories Ltd.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms